TABLE 1.
Baseline Characteristics of Study Participants: Caranguejo Exercise Trial, Recife, Brazil, August 2005 to January 2006
| Treatment Group (n = 78) | Control Group (n = 78) | P | |
| Age, y, mean ±SD | 39.4 ± 11.0 | 37.0 ± 10.6 | .160 |
| Weight, kg, mean ±SD | 71.2 ± 7.82 | 74.5 ± 11.0 | .033 |
| Height, cm, mean ±SD | 155.1 ± 5.5 | 156.9 ± 6.64 | .063 |
| Body mass index, kg/m2, mean ±SD | 29.7 ± 3.13 | 30.3 ± 3.37 | .309 |
| No. children at home, mean ±SD | 3.12 ± 1.59 | 3.18 ± 1.41 | .790 |
| Age, y, no. (%)a | .231 | ||
| < 30 | 19 (26.8) | 20 (26.7) | |
| 30–34 | 12 (16.9) | 24 (32.0) | |
| 35–48 | 18 (25.4) | 15 (20.0) | |
| > 48 | 22 (31.0) | 16 (21.3) | |
| Race/ethnicity, no. (%) | .243 | ||
| Black | 18 (23.1) | 25 (32.1) | |
| White | 42 (53.8) | 42 (53.8) | |
| Mixed | 18 (23.1) | 11 (14.1) | |
| Marital status, no. (%) | .544 | ||
| Married or partnered | 41 (52.6) | 39 (50.0) | |
| Separated or divorced | 24 (30.8) | 22 (28.2) | |
| Widowed | 11 (14.1) | 11 (14.1) | |
| Never married | 2 (2.6) | 6 (7.7) | |
| Income per capita/day, US $, no. (%) | .659 | ||
| ≤ 0.6 | 15 (19.2) | 17 (21.8) | |
| 0.7 | 21 (26.9) | 22 (28.2) | |
| 0.8 | 25 (32.1) | 28 (35.9) | |
| 0.9 | 17 (21.8) | 11 (14.1) | |
| Educational attainment, y, no. (%) | .528 | ||
| ≥ 4 | 43 (55.1) | 46 (59.0) | |
| < 4 | 21 (26.9) | 23 (29.5) | |
| Illiterate | 14 (17.9) | 9 (11.5) | |
| Employment status, no. (%) | .257 | ||
| Employed | 4 (5.1) | 10 (12.8) | |
| Unemployed | 51 (65.4) | 52 (66.7) | |
| Student | 12 (15.4) | 6 (7.7) | |
| Retired | 7 (9.0) | 8 (10.3) | |
| Other | 4 (5.1) | 2 (2.6) | |
| Religious affiliation, no. (%) | .243 | ||
| Catholic | 48 (61.5) | 52 (66.7) | |
| Other | 25 (32.1) | 17 (21.8) | |
| None | 5 (6.4) | 9 (11.5) | |
| Television at home, no. (%) | .731 | ||
| Yes | 73 (93.6) | 74 (94.9) | |
| No | 5 (6.4) | 4 (5.1) | |
| Physical activity, no. (%) | .383 | ||
| Sedentary | 26 (33.3) | 21 (26.9) | |
| Irregularly active | 52 (66.7) | 57 (73.1) |
a
Age data were missing for 3 participants in the control group and 7 in the treatment group.